Search

Author/Creator Bower, Mark

1. A retrospective, multi-center analysis of treatment intensification for human immunodeficiency virus-positive patients with high-risk diffuse large B-cell lymphoma. Issue 9 (September 2013)

Authors:
Kassam, Shireen; Bower, Mark; Lee, Siow Ming; de Vos, Johannes; Fields, Paul; Gandhi, Shreyans; Nelson, Mark; Montoto, Silvia; Tenant-Flowers, Melinda; Burns, Fiona; Marcus, Robert; Edwards, Simon G.; Cwynarski, Kate
Journal:
Leukemia & lymphoma
Issue:
Volume 54:Issue 9(2013:Sep.)
Page Start:
1921
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy. (15th May 2015)

Authors:
Alwan, Ferras; He, Annie; Montoto, Silvia; Kassam, Shireen; Mee, Matthew; Burns, Fiona; Edwards, Simon; Wilson, Andrew; Tenant-Flowers, Melinda; Marcus, Robert; Ardeshna, Kirit M.; Bower, Mark; Cwynarski, Kate
Journal:
AIDS
Issue:
Volume 29:Number 8(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy. (15th May 2015)

Authors:
Alwan, Ferras; He, Annie; Montoto, Silvia; Kassam, Shireen; Mee, Matthew; Burns, Fiona; Edwards, Simon; Wilson, Andrew; Tenant-Flowers, Melinda; Marcus, Robert; Ardeshna, Kirit M.; Bower, Mark; Cwynarski, Kate
Journal:
AIDS
Issue:
Volume 29:Number 8(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗